The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of tasquinimod, an S100A9 inhibitor, alone and in combination with IRd for relapsed and refractory multiple myeloma (RRMM).
 
Dan T. Vogl
Consulting or Advisory Role - CSL Behring; Genentech; Genzyme; GlaxoSmithKline; Karyopharm Therapeutics; Oncopeptides; Takeda
Research Funding - Abbvie (Inst); Active Biotech (Inst); Karyopharm Therapeutics (Inst); Takeda (Inst)
 
Yulia Nefedova
Research Funding - Active Biotech (Inst)
 
E. Paul Wileyto
No Relationships to Disclose
 
Chau T. Nguyen
No Relationships to Disclose
 
Cynthia Diaczynsky
No Relationships to Disclose
 
Abigail Etzweiler
No Relationships to Disclose
 
Inna Strakovsky
No Relationships to Disclose
 
Cindy Lin
No Relationships to Disclose
 
Eva Bondesson
Employment - Active Biotech
 
Helen Tuvesson
Employment - Active Biotech
Leadership - Active Biotech
Stock and Other Ownership Interests - Active Biotech
 
Erik Vahtola
Employment - Active Biotech
 
Adam D. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Janssen; Novartis; Oncopeptides; Takeda
Research Funding - Genentech; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Takeda
 
Sandra P. Susanibar-Adaniya
No Relationships to Disclose
 
Adam J. Waxman
No Relationships to Disclose
 
Alfred L. Garfall
Stock and Other Ownership Interests - Cabaletta Bio
Consulting or Advisory Role - Amgen; CDR-Life; GlaxoSmithKline; Janssen Oncology
Research Funding - crispr therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst); Tmunity Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Patent in the field of CAR T cell therapy
 
Edward Allen Stadtmauer
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Novartis; Sanofi; Takeda; Teva